Compare BYND & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BYND | STIM |
|---|---|---|
| Founded | 2009 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.8M | 120.4M |
| IPO Year | 2018 | 2018 |
| Metric | BYND | STIM |
|---|---|---|
| Price | $7.22 | $2.09 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $12.50 | $5.75 |
| AVG Volume (30 Days) | ★ 1.1M | 685.9K |
| Earning Date | 11-09-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 24.69 | ★ 57.25 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $275,496,000.00 | $52,776,000.00 |
| Revenue This Year | N/A | $8.63 |
| Revenue Next Year | N/A | $9.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.40 | $0.80 |
| 52 Week High | $15.47 | $3.44 |
| Indicator | BYND | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 37.81 | 39.85 |
| Support Level | $0.63 | $1.99 |
| Resistance Level | $12.52 | $2.13 |
| Average True Range (ATR) | 0.41 | 0.10 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 25.91 | 54.09 |
Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.